Health Discovery Corporation (HDVY)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Feb 3, 2026

Health Discovery Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Net Income
-2.91-0.761.56-0.8-0.87-2.07
Depreciation & Amortization
--0.150.260.260.26
Loss (Gain) From Sale of Investments
----0.01-0.01
Stock-Based Compensation
1.370.270.510.090.070.2
Other Operating Activities
--0.99----0.07
Change in Accounts Payable
0.290.11-0.13-00.110.07
Change in Unearned Revenue
---0.02-0.04-0.04-0.04
Change in Other Net Operating Assets
0.02-00.120.220.151.2
Operating Cash Flow
-1.24-1.382.2-0.28-0.31-0.47
Investment in Securities
----0.14-
Investing Cash Flow
----0.14-
Long-Term Debt Issued
--0.090.230.18-
Net Debt Issued (Repaid)
--0.090.230.18-
Issuance of Common Stock
0.23----0.09
Financing Cash Flow
0.23-0.090.230.180.09
Net Cash Flow
-1.01-1.382.3-0.040-0.38
Free Cash Flow
-1.24-1.382.2-0.28-0.31-0.47
Free Cash Flow Margin
--137900.00%145.03%-621.98%-698.55%-1070.87%
Free Cash Flow Per Share
-0.00-0.000.01-0.00-0.00-0.00
Levered Free Cash Flow
0.3-2.832.520.040.05-0.47
Unlevered Free Cash Flow
0.31-2.822.540.060.05-0.47
Change in Working Capital
0.310.1-0.020.170.221.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.